An investigation into the factors, constraints and potential barriers which might limit the ability of community pharmacists to contribute to the limitation of antipsychotics use in the treatment of behavioural and psychological symptoms of dementia (BPSD) identifies:
- Politics and the medical hierarchy, resulting in communication barriers.
- The impact resources and remit on the effectiveness of community pharmacies
- Understanding the nature of dementia and its treatment.
Maidment, ID. Aston, L. [and] Hilton, A. [et al] (2016). Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD): a qualitative study. BMJ Open, 2016, Vol.6(3), e010278. (Click here to view the PubMed abstract).